Diabetes consequences in the fetus liver of the non-obese diabetic mice
- PMID: 28319104
- PMCID: PMC5380899
- DOI: 10.1038/nutd.2017.7
Diabetes consequences in the fetus liver of the non-obese diabetic mice
Abstract
DM type 1 (T1D) incidence is increasing around 3% every year and represents risks for maternal and fetal health. The objective of this study was to explore the effects of diabetes on fetus liver cells in non-obese diabetic (NOD) mice. Hyperglycemic NOD (HNOD), normoglycemic NOD (NNOD) and BALB/c females were used for mating, and the fetus livers were collected at 19.5 gestation day (gd). HNOD group had reduced fetal weight (989.5±68.32 vs 1290±57.39 mg BALB/c, P<0.05) at 19.5 gd and higher glycemia (516.66±28.86 mg dl-1, P<0.001) at both 0.5 gd and 19.5 gd compared to other groups. The protein expression of albumin (ALB) was significantly reduced in HNOD group (0.9±0.2 vs 3.36±0.36 NNOD P<0.01, vs 14.1±0.49 BALB/c P<0.001). Reduced gene expression of ALB (1.34±0.12 vs 5.53±0.89 NNOD and 5.23±0.71 BALB/c, P<0.05), Hepatic Nuclear Factor-4 alpha (HNF-4α) (0.69±0.1 vs 3.66±0.36 NNOD, P<0.05) and miR-122 (0.27±0,10 vs 0.88±0.15 NNOD, P<0.05) was present in HNOD group. No difference for alpha-Fetoprotein (AFP) and gene expression was observed. In conclusion, our findings show the impacts of T1D on the expression of ALB, AFP, HNF-4α and miR-122 in fetus liver cells by using NNOD and HNOD mice.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Quantitative gene expression profiling reveals a fetal hepatic phenotype of murine ES-derived hepatocytes.Int J Dev Biol. 2004 Feb;48(1):23-9. doi: 10.1387/ijdb.15005571. Int J Dev Biol. 2004. PMID: 15005571
-
HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells.Eur J Pharmacol. 2016 Nov 15;791:254-263. doi: 10.1016/j.ejphar.2016.08.038. Epub 2016 Aug 31. Eur J Pharmacol. 2016. PMID: 27592052
-
Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.Life Sci. 2013 Nov 19;93(22):805-13. doi: 10.1016/j.lfs.2013.10.011. Epub 2013 Oct 21. Life Sci. 2013. PMID: 24157454
-
[Curative effects of transplantation of hepatocytes differentiated from embryonic stem cells on treatment of fulminant hepatic failure: experiment with mice].Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3280-4. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17313811 Chinese.
-
Polyploidy and chromatin remodeling in hepatocytes from insulin-dependent diabetic and normoglycemic aged mice.Cytometry A. 2012 Sep;81(9):755-64. doi: 10.1002/cyto.a.22102. Epub 2012 Jul 26. Cytometry A. 2012. PMID: 22837107
References
-
- International Diabetes Federation (IDF). Diabetes Atlas. IDF: Brussels, Belgium, 7th ed. 2015 1–144.
-
- Schaffer SW, Mozaffari MS. The neonatal STZ model of diabetes. In: McNeill JH editor. Experimental models of diabetes. CRC Press: Boca Raton, FL, USA, 1999; 231–255.
-
- Wicker LS, Clark J, Fraser HI, Garner VES, Gonzalez-Munoz A, Healy B et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 2005; 25: 29–33. - PubMed
-
- Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735–739. - PubMed
-
- Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122–a key factor and therapeutic target in liver disease. J Hepatol 2015; 62: 448–457. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous